DeepSight Technology Adds Scott Huennekens to Board
DeepSight Technology appointed former Volcano and Verb Surgical CEO Scott Huennekens to its board following the completion of a Series C financing.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
DeepSight Technology appointed former Volcano and Verb Surgical CEO Scott Huennekens to its board following the completion of a Series C financing.
Flo Health and Google Health will connect cycle insights with wearable data and develop AI models for women's health under a multi year partnership.
Immorta Bio completed planned preclinical studies of SenoMune-0257, a nine amino acid peptide designed to help the immune system eliminate senescent cells. The company plans initial human testing before the end of 2026.
POMDOCTOR plans to combine AI, wearable devices, remote patient monitoring and healthcare data with its physician network and existing services.
Lunit and Discovery Life Sciences will combine AI pathology with biospecimen and laboratory services for biomarker research and drug development.
Emplify Health will use Pearl Health's predictive analytics and risk management tools to support care for about 25,000 Medicare beneficiaries starting in 2027.
Sopris Capital completed its acquisition of medical imaging AI company Blackford Analysis from Bayer and plans to combine it with Azra AI.
The NATIVE-ID project will combine AI, cell experiments and protein data to predict harmful changes linked to neurodegenerative diseases.
AnX Robotica says an FDA filing shows NaviCam ProScan reduced mean small bowel capsule review time from 33 minutes 42 seconds to 3 minutes 50 seconds.
Assort Health and Nextech will codevelop an AI agent offering for Nextech customers, with deeper integration for ophthalmology scheduling and patient access workflows.
PhyPal has relaunched its patient engagement platform with conversational AI, clinical workflows, and tools for treatment authorization and outcomes tracking.
Four studies examine whether the HelioLiver blood test can detect liver cancer signals when ultrasound is negative, imaging is inconclusive or tumors are not yet visible.
GenScript and NVIDIA opened applications for a global startup competition focused on AI in therapeutic discovery and life sciences. Up to six finalists will pitch during JPM Week in January.
Xtalks will host a free webinar on October 28 about high throughput antibody workflows, laboratory automation and data integration for AI based process optimization.
The Saffron Solution will demonstrate more than 50 applications for ophthalmology practices at AAO 2026, including AI assistants, automation tools, and surgery management software.
Apodex is offering small and midsize drug developers free access to AI agents, computing resources and biomedical evidence for research.
Araceli Biosciences has integrated its Endeavor cellular imaging instrument into Ginkgo Bioworks' autonomous Nebula lab in Boston.
Veeva Systems will present Falcon, Vault AI and new software capabilities at its R&D and Quality Summit in Boston on October 20 and 21.
Canary Speech has integrated its vocal analysis technology into VillageFor's voice journal, giving mothers another way to monitor their emotional wellness.
Vocca raised a $20 million Series A led by Norrsken VC to expand its AI phone assistant for medical practices in the United States and Europe.